UAE - Khalaf Al Habtoor, founding Chairman of Al Habtoor Group (AHG), has announced a generous aid to help fight the novel coronavirus, Covid-19, in UAE.

The Emirati business tycoon and philanthropist received Humaid Al Qutami, Director-General of the Dubai Health Authority (DHA), and extended his full backing in support of the country's fight against Covid-19.

Al Habtoor is donating 50 ambulances to the UAE health authorities, to be used in the country's fully integrated response against the coronavirus.

In addition to the ambulances, the AHG Chairman has also allocated a fully equipped building of more than 100 rooms to DHA, for the purpose of quarantining coronavirus affected patients.

He has also committed to building a specialised laboratory for research on viruses and epidemic control, in collaboration with the DHA and Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU).

Al Habtoor said: "In the time of a global pandemic, we need to direct all our efforts in identifying and defeating the virus as early as possible and as quickly as possible. I hope our contributions will aid the UAE's public health authorities' actions in protecting the safety and well-being of its citizens and residents. The UAE has demonstrated a well thought-out and resilient approach in combating coronavirus, with preventative measures, closures of public facilities and travel control measures."

The entrepreneur has made generous donations to war-stricken refugees, and several other initiatives in the UAE and abroad.

Copyright © 2020 Khaleej Times. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.